한글목차

정밀의료 동향과 전망

세계 정밀의학 시장은 2024년부터 2030년까지 9.5%의 연평균 복합 성장률(CAGR)로 2030년까지 약 1,436억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 개인 맞춤형 치료에 대한 수요 증가와 동반 진단 및 유전자 검사에 대한 선호도 증가입니다. 세계 정밀의학 시장의 미래는 종양, 희귀질환, 감염성 질환, 혈액질환 시장에서 기회가 있으며 유망한 시장으로 평가받고 있습니다.

부문별 정밀의학

이 보고서는 세계 정밀의료의 유형별, 적응증별, 최종 용도별, 지역별 예측을 담고 있습니다.

정밀의료 시장 인사이트

Lucintel은 예측 기간 동안 억제제가 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

이 시장에서 종양은 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상됩니다.

북미는 예측 기간 동안 가장 규모가 큰 지역이 될 것으로 예상됩니다.

자주 묻는 질문

Q1. 시장 규모 :

A1. 세계 정밀의료 시장은 2030년까지 약 1,436억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 예측은 다음과 같습니다.

A2. 세계 정밀의학 시장은 2024년부터 2030년까지 연평균 9.5%의 성장률을 보일 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 다음과 같습니다.

A3. 이 시장의 주요 촉진요인은 개인 맞춤형 치료에 대한 수요 증가와 동반 진단 및 유전자 검사에 대한 선호도 증가입니다.

Q4. 시장의 주요 부문은 다음과 같습니다.

A4. 정밀의학 시장의 미래는 종양, 희귀질환, 감염질환, 혈액질환 등 다양한 분야에서 기회가 있을 것으로 예상됩니다.

Q5. 시장 주요 기업은 다음과 같습니다.

A5.정밀의료 주요 기업은 다음과 같습니다.

• Hoffmann-La Roche
• Novartis
• Pfizer
• Bristol Myers Squibb
• AstraZeneca
• Gilead Sciences
• AbbVie
• Eli Lilly and Company
• GlaxoSmithKline
• Sanofi

Q6. 향후 가장 큰 시장 부문은 다음과 같습니다.

A6. Lucintel은 예측 기간 동안 억제제가 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

Q7. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디입니까?

A7. 북미는 예측 기간 동안 가장 규모가 큰 지역이 될 것으로 예상됩니다.

Q8. 보고서 사용자 정의가 가능합니까?

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 정밀의료 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 정밀의료 시장 동향(2018-2023년)과 예측(2024-2030년)
• 유형별 세계의 정밀의료 시장
  • 억제제
  • 단클론항체
  • 세포 및 유전자 치료
  • 항바이러스제 및 항레트로바이러스제
  • 기타
• 적응증별 세계의 정밀의료 시장
  • 종양
  • 희귀질환
  • 감염증
  • 혈액질환
  • 기타
• 최종 용도별 세계의 정밀의료 시장
  • 병원 및 클리닉
  • 재택치료

제4장 지역별 시장 동향과 예측 분석(2018-2023년)

• 지역별 세계의 정밀의료 시장
• 북미의 정밀의료 시장
• 유럽의 정밀의료 시장
• 아시아태평양의 정밀의료 시장
• 기타 지역의 정밀의료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
• 세계 정밀의료 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 정밀의료 시장 능력 확대
  • 세계 정밀의료 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증과 라이선싱

제7장 주요 기업 개요

• Hoffmann-La Roche
• Novartis
• Pfizer
• Bristol Myers Squibb
• AstraZeneca
• Gilead Sciences
• AbbVie
• Eli Lilly and Company
• GlaxoSmithKline
• Sanofi

영문목차

Precision Medicine Trends and Forecast

The future of the global precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets. The global precision medicine market is expected to reach an estimated $143.6 billion by 2030 with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Precision Medicine by Segment

The study includes a forecast for the global precision medicine by type, indication, end use, and region.

Precision Medicine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Inhibitor Drugs
• Monoclonal Antibodies
• Cell & Gene Therapy
• Antiviral & Anti-Retroviral Drugs
• Others

Precision Medicine Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Oncology
• Rare Diseases
• Infectious Diseases
• Hematological Disorders
• Others

Precision Medicine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Home Care Settings

Precision Medicine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Precision Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies precision medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the precision medicine companies profiled in this report include-

• Hoffmann-La Roche
• Novartis
• Pfizer
• Bristol Myers Squibb
• AstraZeneca
• Gilead Sciences
• AbbVie
• Eli Lilly and Company
• GlaxoSmithKline
• Sanofi

Precision Medicine Market Insights

Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Within this market, oncology will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Precision Medicine Market

Market Size Estimates: Precision medicine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Precision medicine market size by type, indication, end use, and region in terms of value ($B).

Regional Analysis: Precision medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, indications, end uses, and regions for the precision medicine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the precision medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the precision medicine market size?

Answer: The global precision medicine market is expected to reach an estimated $143.6 billion by 2030.

Q2. What is the growth forecast for precision medicine market?

Answer: The global precision medicine market is expected to grow with a CAGR of 9.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the precision medicine market?

Answer: The major drivers for this market are increasing demand for personalized treatment and rising preference for companion diagnostics & genetic testing.

Q4. What are the major segments for precision medicine market?

Answer: The future of the precision medicine market looks promising with opportunities in the oncology, rare disease, infectious disease, and hematological disorder markets.

Q5. Who are the key precision medicine market companies?

Answer: Some of the key precision medicine companies are as follows:

• Hoffmann-La Roche
• Novartis
• Pfizer
• Bristol Myers Squibb
• AstraZeneca
• Gilead Sciences
• AbbVie
• Eli Lilly and Company
• GlaxoSmithKline
• Sanofi

Q6. Which precision medicine market segment will be the largest in future?

Answer: Lucintel forecasts that inhibitor drug will remain the largest segment over the forecast period.

Q7. In precision medicine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the precision medicine market by type (inhibitor drugs, monoclonal antibodies, cell & gene therapy, antiviral & anti-retroviral drugs, and others), indication (oncology, rare diseases, infectious diseases, hematological disorders, and others), end use (hospitals & clinics and home care settings), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Precision Medicine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Precision Medicine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Precision Medicine Market by Type
  • 3.3.1: Inhibitor Drugs
  • 3.3.2: Monoclonal Antibodies
  • 3.3.3: Cell & Gene Therapy
  • 3.3.4: Antiviral & Anti-Retroviral Drugs
  • 3.3.5: Others
• 3.4: Global Precision Medicine Market by Indication
  • 3.4.1: Oncology
  • 3.4.2: Rare Diseases
  • 3.4.3: Infectious Diseases
  • 3.4.4: Hematological Disorders
  • 3.4.5: Others
• 3.5: Global Precision Medicine Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Home Care Settings

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Precision Medicine Market by Region
• 4.2: North American Precision Medicine Market
  • 4.2.1: North American Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
  • 4.2.2: North American Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
• 4.3: European Precision Medicine Market
  • 4.3.1: European Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
  • 4.3.2: European Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
• 4.4: APAC Precision Medicine Market
  • 4.4.1: APAC Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
  • 4.4.2: APAC Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others
• 4.5: ROW Precision Medicine Market
  • 4.5.1: ROW Precision Medicine Market by Type: Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, and Others
  • 4.5.2: ROW Precision Medicine Market by Indication: Oncology, Rare Diseases, Infectious Diseases, Hematological Disorders, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Precision Medicine Market by Type
  • 6.1.2: Growth Opportunities for the Global Precision Medicine Market by Indication
  • 6.1.3: Growth Opportunities for the Global Precision Medicine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Precision Medicine Market by Region
• 6.2: Emerging Trends in the Global Precision Medicine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Precision Medicine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Precision Medicine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Novartis
• 7.3: Pfizer
• 7.4: Bristol Myers Squibb
• 7.5: AstraZeneca
• 7.6: Gilead Sciences
• 7.7: AbbVie
• 7.8: Eli Lilly and Company
• 7.9: GlaxoSmithKline
• 7.10: Sanofi